marijuana stocks

Advanced Cannabis Solutions, Inc. (CANN)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Mar 31, 2014 Dec 31, 2013
Total Revenue 97   14   49   (22)
Cost of Revenue 66 (15) – (12)
Gross Profit 31   29   49   (9)
Operating Expenses
Research Development – – – –
Selling General and Administrative 735 1,342 961 233
Non Recurring – – – –
Others 47 13 3 –
Total Operating Expenses – – – –
Operating Income or Loss (752) (1,325) (915) (242)
Income from Continuing Operations
Total Other Income/Expenses Net (2,962) (346) (953) (1)
Earnings Before Interest And Taxes (3,714) (1,671) (1,869) (243)
Interest Expense 41 76 50 1
Income Before Tax (3,755) (1,747) (1,919) (244)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (3,755) (1,747) (1,919) (244)
Non-recurring Events
Discontinued Operations – – 2 11
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (3,755) (1,747) (1,917) (233)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (3,755) (1,747) (1,917) (233)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

InMed Pharmaceuticals Inc. (IMLFF) Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D…

$CMM.V shows dramatic reduction in pharmaceutical reliance

Milestone study shows dramatic reduction in pharmaceutical reliance among Canadian medical cannabis…

Tetra Bio-Pharma Inc. (TBPMF) getting ready to file a clinical trial application to initiate phase 3 clinical trial

Tetra Bio-Pharma getting ready to file a clinical trial application to initiate…

Tauriga Sciences, Inc. (TAUG) Enters into Confidential Settlement Agreement

Tauriga Sciences, Inc. Enters into Confidential Settlement Agreement and General Releases in…